Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Allergan (AGN) initiated with an Outperform at Credit Suisse. 2. VMware (VMW) initiated with an Overweight at Morgan Stanley. 3. Syros Pharmaceuticals (SYRS) initiated with an Overweight at Piper Jaffray, an Outperform at JMP Securities, an Outperform at Cowen, and an Outperform at Wedbush. 4. Level 3 (LVLT) initiated with a Sector Weight at Pacific Crest. 5. KeyCorp (KEY) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Sees FY24 noninterest income up 5%+. Sees relatively stable noninterest expense vs. FY23, net charge-offs 30-40bps, and a GAAP tax rate of about 20%.

In the long term the company expects: positive operating leverage, cash efficiency ratio of 54%-56%, net charge-offs to average loans 40-60 basis points and ROTCE 16%-19%. Guidance taken from Q1 investor presentation slides.